Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Prepaid Assets (2019 - 2025)

Nurix Therapeutics (NRIX) has disclosed Prepaid Assets for 7 consecutive years, with $13.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 41.55% to $13.9 million in Q4 2025 year-over-year; TTM through Nov 2025 was $13.9 million, a 41.55% increase, with the full-year FY2025 number at $13.9 million, up 41.55% from a year prior.
  • Prepaid Assets was $13.9 million for Q4 2025 at Nurix Therapeutics, up from $11.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $14.0 million in Q1 2025 to a low of $3.7 million in Q1 2021.
  • A 5-year average of $9.2 million and a median of $9.3 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 177.38% in 2022, then crashed 37.62% in 2024.
  • Nurix Therapeutics' Prepaid Assets stood at $9.2 million in 2021, then increased by 1.24% to $9.3 million in 2022, then fell by 18.4% to $7.6 million in 2023, then rose by 29.08% to $9.8 million in 2024, then soared by 41.55% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for NRIX's Prepaid Assets are $13.9 million (Q4 2025), $11.8 million (Q3 2025), and $10.5 million (Q2 2025).